Related Experiment Video
Updated: Sep 28, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Treatment of diabetic retinopathy
1Department of Ophthalmology, Royal Victorian Eye and Ear Hospital, 32 Gisborne Street, East Melbourne, Victoria, 3002, Australia.
Abstract:
Diabetic retinopathy is a major public health problem and it remains the leading cause of blindness in people of working age (20 to 65 years). Several important clinical trials have given us the evidence base to provide clinical practice guidelines for management of this disease. With full implementation of existing technology, it should be possible to greatly improve visual outcomes for people with diabetes. There are two keys to maintaining vision in people with diabetes. First, achieving good long-term metabolic control of diabetes will limit the development and progression of diabetic retinopathy. Second, ensuring early detection of diabetic retinopathy by regular (two-yearly at least) screening examinations will allow timely referral for application of retinal photocoagulation. This paper will review the ophthalmologist's treatment of diabetic retinopathy with emphasis on the role of photocoagulation.
Related Concept Videos
Diabetic Retinopathy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Nephropathy
Angle Closure Glaucoma: Treatment
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Neuropathy
